Form 4/A for CVS CVS Health
Accepted 2022-06-30 00:00:00 ET · period of report 2022-05-31 · accession 0000947871-22-000732 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-06-30 | 2022-05-31 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | — | 0 | 0 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (RSU) | 2022-05-31 | A | A | 0 | $0.00 | 0 | D | — | — | (F1) This Form 4/A is being filed to amend a Form 4 filed by Dr. Chaguturu on 06/06/2022, which incorrectly reported an award of Restricted Stock Units ("RSUs") with respect to 12,919 shares of the Issuer's common stock. The Form 4 filing was the result of an administrative error. |